An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion

Area of Science:

• Biochemistry
• Enzyme Assays
• Metabolic Disorders

Background:

• Medium chain acyl-CoA dehydrogenase (MCAD) is crucial for fatty acid metabolism.
• Assays for MCAD activity are important for diagnosing MCAD deficiency, a metabolic disorder.
• Current assays often rely on electron transferring flavoprotein (ETF), which requires purification and specific conditions.

Purpose of the Study:

• To develop a novel, sensitive, and convenient assay for medium chain acyl-CoA dehydrogenase (MCAD).
• To replace the physiological electron acceptor, ETF, with a more accessible oxidant.
• To establish a reliable screening method for MCAD deficiency.

Main Methods:

• Development of a new assay utilizing ferricenium hexafluorophosphate as an electron acceptor.
• Characterization of the ferricenium ion's oxidative properties with octanoyl-CoA-reduced enzyme.
• Comparison of the ferricenium assay with the traditional ETF-based assay using fibroblast homogenates.

Main Results:

• The ferricenium assay demonstrated high Vmax (1400 min-1) and a suitable KM (55 microM) at pH 7.6.
• The assay does not require mediator dyes or purified ETF and can be performed aerobically.
• Comparable results were obtained between the ferricenium and ETF assays in patient samples.

Conclusions:

• Ferricenium hexafluorophosphate provides a sensitive and convenient alternative to ETF for MCAD activity assays.
• The developed assay simplifies MCAD deficiency screening and may be applicable to other acyl-CoA dehydrogenases.
• This method offers advantages in terms of reagent availability and experimental conditions.